Health Canada Secures Permanent Injunction Against Quebec Peptide Vendor Canlab Research
Canada’s health regulator obtained a permanent injunction from the Superior Court of Québec prohibiting Quebec‑based online retailer Canlab Research from manufacturing, testing, distributing, selling or advertising unauthorized injectable peptide products. The court order follows a temporary injunction issued in 2024 after Health Canada repeatedly warned that the company marketed peptides with unproven claims for anti‑aging, weight loss, bodybuilding and athletic performance. Health Canada highlighted serious health risks, noting that such unauthorized peptides can cause hormonal imbalance, mood swings, blood‑sugar disruption, liver or kidney damage, blood clots and possible tumor growth. In Canada, injectable peptides are classified as prescription drugs and must be authorized before sale. Canlab Research’s website now carries a legal notice dated April 2025 stating it is complying with the court’s directives.
Entities: Canada · Canlab Research · Health Canada · Quebec · Superior Court of Québec
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 6 SOURCES] Health Canada had previously warned consumers about serious health risks from unauthorized injectable peptides sold by Canlab Research. (Health Canada public warnings)
- [● 5 SOURCES] Canlab Research’s website displays a legal notice dated April 2025 stating it is complying with the court directives. (Canlab Research website)
- [● 6 SOURCES] Health Canada obtained a permanent injunction against Canlab Research. (Health Canada and the Superior Court of Québec)
- [● 6 SOURCES] The injunction was granted by the Superior Court of Québec. (Superior Court of Québec)
- [● 5 SOURCES] A temporary injunction against Canlab Research was issued in 2024 before the permanent order. (Court records)
- [● 6 SOURCES] The injunction blocks Canlab Research from manufacturing, testing, distributing, selling or advertising unauthorized injectable peptides in Canada. (Health Canada statement and court order)
- [● 6 SOURCES] Injectable peptides are classified as prescription drugs in Canada and must be authorized before sale. (Health Canada regulation)
- [● 6 SOURCES] Unauthorized injectable peptides can cause hormonal imbalance, mood swings, blood‑sugar disruption, liver or kidney damage, blood clots and may promote tumor growth. (Health Canada advisory)